Project Details
Description
The objectives of this study are (1) to determine the ex vivo neutralizing capacity and the longevity of SARS-CoV-2-specific Ab responses and (2) to measure the MBC responses in a cohort of health care workers (HCW) recovering from severe, mild or asymptomatic infection. By focusing on HCW, a population that is at risk for re-infection during a second epidemic wave, we also aim to correlate nAb levels with protection.
Acronym | ImmCoV |
---|---|
Status | Active |
Effective start/end date | 22/05/20 → 31/05/23 |
Funding
- Fonds voor Wetenschappelijk Onderzoek: €115,770.00